Skip to main content
Premium Trial:

Request an Annual Quote

ArcherDX's VariantPlex p53 Panel for Targeted NGS

ArcherDX has expanded the application of its Anchored Multiplex PCR (AMP) technology to include DNA variant detection with the Archer VariantPlex p53 panel. The panel is a targeted next-generation sequencing-based assay to detect germline and somatic mutations of the TP53 gene, which is frequently mutated in cancer. The assays' use a simple lyophilized workflow optimized to minimize hands-on time and contamination risk during library preparation, making them ideal for high-volume laboratories, said ArcherDX in a statement. The AMP-enabled VariantPlex panels are target enrichment assays used to create libraries for Illumina or Ion Torrent sequencing from small amounts (10-200ng) of nucleic acid extracted from formalin-fixed, paraffin-embedded (FFPE) clinical samples. Once sequenced, the Archer Analysis software provides comprehensive analysis with embedded QC metrics and read visualization to accurately detect and identify known and novel fusions, single nucleotide variants, insertion/deletions and copy number variants.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.